INTS
USDIntensity Therapeutics Inc. Common stock
$0.455-0.035 (-7.122%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.490
High
$0.503
Low
$0.430
Volume
14.52M
Company Fundamentals
Market Cap
27.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
30.37M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.185Current $0.455High $3.399
Related News
PR Newswire
Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and...
View more
Related Stocks
BSRR
Sierra Bancorp
NASDAQ
Major Banks
JCE
Nuveen Core Equity Alpha Fund Common Shares of Beneficial Interest
NASDAQ
Trusts Except E...
TCPC
BlackRock TCP Capital Corp.
NASDAQ
Finance/Investo...
VPV
Invesco Pennsylvania Value Municipal Income Trust (DE)
NASDAQ
Trusts Except E...
INSI
Insight Select Income Fund
NASDAQ
Investment Mana...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.